We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
-3.54%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$20.7B
AUM Growth
+$696M
Cap. Flow
+$853M
Cap. Flow %
4.12%
Top 10 Hldgs %
37.98%
Holding
357
New
50
Increased
42
Reduced
43
Closed
37

Top Buys

Rank Stock Value
1
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
+$391M
2
TRU icon
TransUnion
TRU
+$345M
3
CERN
Cerner Corp
CERN
+$309M
4
XYZ
Block Inc
XYZ
+$266M
5
ATVI
Activision Blizzard
ATVI
+$261M

Top Sells

Rank Stock Value
1
XLNX
Xilinx Inc
XLNX
+$561M
2
BBL
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
+$406M
3
RTX icon
RTX Corp
RTX
+$227M
4
CHTR icon
Charter Communications
CHTR
+$206M
5
NUAN
Nuance Communications, Inc.
NUAN
+$190M

Sector Composition

Rank Sector Weight
1 Healthcare 28.91%
2 Technology 15.84%
3 Financials 13.74%
4 Industrials 11.77%
5 Communication Services 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVMD icon
51
Revolution Medicines
RVMD
$44B
$82.9M 0.4%
3,250,000
+500,000
+18% +$10.9M
CTLT
52
DELISTED
CATALENT, INC.
CTLT
$79.5M 0.38%
716,555
-47,006
-6% -$4.91M
SRPT icon
53
Sarepta Therapeutics
SRPT
$1.77B
$77.5M 0.37%
991,975
+152,966
+18% +$11.7M
ZEN
54
DELISTED
ZENDESK INC
ZEN
$75.8M 0.37%
630,000
+200,000
+47% +$21.7M
PCG icon
55
PG&E
PCG
$38.5B
$75.3M 0.36%
6,305,142
– –
AMRS
56
DELISTED
Amyris Inc.
AMRS
$73.8M 0.36%
16,931,427
+6,071,616
+56% +$27.2M
INSP icon
57
Inspire Medical Systems
INSP
$1.74B
$72.8M 0.35%
+283,500
New +$64.8M
CHNG
58
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$71.4M 0.34%
3,273,600
– –
CYTK icon
59
Cytokinetics
CYTK
$10.4B
$69.3M 0.33%
1,882,599
-287,743
-13% -$10.2M
BRKR icon
60
Bruker
BRKR
$8.14B
$68.3M 0.33%
1,061,800
+316,534
+42% +$21.6M
UTHR icon
61
United Therapeutics
UTHR
$23.1B
$68.1M 0.33%
379,696
+58,936
+18% +$11.2M
HR icon
62
Healthcare Realty
HR
$6.84B
$64.1M 0.31%
+2,044,181
New +$64.4M
ATTO
63
DELISTED
Atento S.A.
ATTO
$61.7M 0.3%
2,230,357
– –
EXAS
64
DELISTED
Exact Sciences
EXAS
$56.1M 0.27%
802,898
+481,000
+149% +$35.2M
JAZZ icon
65
Jazz Pharmaceuticals
JAZZ
$16.7B
$51.2M 0.25%
329,000
-102,021
-24% -$14.8M
IMGO
66
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
$47.6M 0.23%
2,471,313
– –
OCDX
67
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
$45.3M 0.22%
+2,426,913
New +$43.7M
NTRA icon
68
Natera
NTRA
$46.4B
$44.8M 0.22%
1,101,252
-371,463
-25% -$22.3M
KRTX
69
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$44.4M 0.21%
350,000
-200,000
-36% -$22.5M
DIDI
70
DELISTED
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
$42.2M 0.2%
+16,868,328
New +$66.6M
BRMK
71
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
$42M 0.2%
4,850,000
– –
RGEN icon
72
Repligen
RGEN
$9.25B
$41.9M 0.2%
222,979
+86,734
+64% +$16.5M
BIIB icon
73
Biogen
BIIB
$30.7B
$41.7M 0.2%
197,799
+50,090
+34% +$10.9M
AGIO icon
74
Agios Pharmaceuticals
AGIO
$1.93B
$38.8M 0.19%
1,333,012
+76,434
+6% +$2.34M
MANT
75
DELISTED
Mantech International Corp
MANT
$32.3M 0.16%
+375,000
New +$30M
1 2
3
4 5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Farallon Capital Management held 357 positions worth $20.7B, up 3.5% from $20B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Farallon Capital Management deployed $853M of net new capital in Q1 2022, opening 50 new positions and adding to 42 existing holdings. Its largest new stake was ZYNGA INC. CL A COMMON: 44,475,000 shares worth $411M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was RTX Corp, an estimated $227M trimmed.

  • Farallon Capital Management's largest Q1 2022 buy was ZYNGA INC. CL A COMMON: 44,475,000 shares worth $411M.
  • Farallon Capital Management added most to TransUnion in Q1 2022, an estimated $345M increase.
  • Farallon Capital Management's biggest Q1 2022 reduction was RTX Corp, cutting an estimated $227M.
  • Farallon Capital Management fully exited Xilinx Inc in Q1 2022, selling an estimated $561M.
  • Farallon Capital Management's ten largest holdings make up 38% of its $20.7B portfolio in Q1 2022.
  • Farallon Capital Management opened 50 new positions and closed 37 in Q1 2022.
  • Farallon Capital Management's portfolio value rose 3.5% quarter-over-quarter to $20.7B.

Based on Farallon Capital Management's 13F filing for Q1 2022, filed 16 May 2022.